This test is based on the evaluation of three methylation biomarkers, TRNA-Cys, SIM2, and NKX1-1, and showed a sensitivity of 93.5% and a specificity of 92.6% in detecting bladder cancer. The gene discussed is SIM2; the disease is urinary bladder cancer.